Jieying Zhang Selected Research

Apolipoproteins

1/2009

A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jieying Zhang Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 05/2013
3	Hyperthermia 01/2018 - 02/2013
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2022 - 05/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 06/2019
2	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2021
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2021
2	Lymphatic Metastasis 06/2019 - 05/2013
2	Body Weight (Weight, Body) 06/2010 - 01/2009
1	Epilepsy (Aura) 08/2021
1	Tuberous Sclerosis (Bourneville's Disease) 08/2021
1	Microsatellite Instability 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Myopia 01/2020
1	COVID-19 01/2020
1	Infections 06/2019
1	Demyelinating Diseases (Demyelinating Disease) 06/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2015
1	Adenocarcinoma 05/2013
1	Overweight 06/2010
1	Carcinogenesis 05/2002
1	Adenoma (Adenomas) 05/2002

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
2	KynurenineIBA 01/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 06/2010 - 01/2009
1	Diphosphonates (Bisphosphonates)IBA 02/2022
1	Denosumab FDA Link 02/2022
1	InterferonsIBA 02/2022
1	16S Ribosomal RNAIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	trans-sodium crocetinate (crocetin)IBA 08/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	InflammasomesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	3-Hydroxyanthranilic AcidIBA 01/2021
1	Atropine FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2019
1	CateninsIBA 06/2019
1	VimentinIBA 06/2019
1	Cadherins (E-Cadherin)IBA 06/2019
1	Fibronectins (Fibronectin)IBA 06/2019
1	CuprizoneIBA 06/2019
1	Angiotensin IIIBA 01/2019
1	ChemokinesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Drug CarriersIBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Peptides (Polypeptides)IBA 06/2016
1	GATA1 Transcription FactorIBA 02/2015
1	Transcription Factors (Transcription Factor)IBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2015
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 02/2015
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2013
1	Biological ProductsIBA 05/2013
1	ParaffinIBA 05/2013
1	Protamines (Protamine Sulfate)FDA Link 02/2013
1	oxidized low density lipoproteinIBA 06/2010
1	LDL CholesterolIBA 01/2009
1	ApolipoproteinsIBA 01/2009
1	LipidsIBA 01/2009
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2002
1	beta CateninIBA 05/2002

Therapy/Procedure

3	Therapeutics 02/2022 - 01/2018
2	Chemoradiotherapy 07/2022 - 05/2022
1	Immunotherapy 11/2019